Invesaro

Stocks Comparison

NewGenIvf vs Viemed Healthcare: revenue, profit, margins and growth compared

NewGenIvf brought in $23.7M of revenue in fiscal 2025, Viemed Healthcare $270.3M in fiscal 2025. Revenue changed by +336.3% at NewGenIvf and +20.5% at Viemed Healthcare on the year before, so NewGenIvf grew faster. NewGenIvf kept 41.7% of its revenue as net profit, Viemed Healthcare 5.5%. Free cash flow was -$11.1M at NewGenIvf and $11.9M at Viemed Healthcare.

Side by side, latest fiscal year

NIVFVMD
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$23.7M$270.3M
Revenue growth+336.3%+20.5%
Net income$9.9M$14.9M
Net margin41.7%5.5%
Free cash flow-$11.1M$11.9M
Free cash flow margin-46.7%4.4%
Earnings per share (diluted)$3.04$0.37
Cash$758.6K$13.5M
Debtn/a$12.4M
Price to earningsn/a24.1
Market value$3.3M$339.4M
Dividend yieldn/an/a
Rank by revenue in sector#425 of 646 · Health care#234 of 646 · Health care

Over the years

Revenue
NIVF FY2021: $4.1MNIVF FY2023: $5.9MNIVF FY2023: $5.1MNIVF FY2024: $5.4MNIVF FY2025: $23.7MVMD FY2019: $64.5MVMD FY2019: $80.3MVMD FY2020: $131.3MVMD FY2021: $117.1MVMD FY2022: $138.8MVMD FY2023: $183MVMD FY2024: $224.3MVMD FY2025: $270.3MFY19FY20FY21FY22FY23FY24FY25
NIVF $23.7MVMD $270.3M
Net income
NIVF FY2021: -$533NIVF FY2023: $458.7KNIVF FY2023: $130.2KNIVF FY2024: -$524.6KNIVF FY2025: $9.9MVMD FY2019: $9.5MVMD FY2019: $8.5MVMD FY2020: $31.5MVMD FY2021: $9.1MVMD FY2022: $6.2MVMD FY2023: $10.2MVMD FY2024: $11.3MVMD FY2025: $14.9MFY19FY20FY21FY22FY23FY24FY25
NIVF $9.9MVMD $14.9M
Net margin
NIVF FY2021: -0.0%NIVF FY2023: 7.7%NIVF FY2023: 2.5%NIVF FY2024: -9.7%NIVF FY2025: 41.7%VMD FY2019: 14.7%VMD FY2019: 10.6%VMD FY2020: 24.0%VMD FY2021: 7.8%VMD FY2022: 4.5%VMD FY2023: 5.6%VMD FY2024: 5.0%VMD FY2025: 5.5%FY19FY20FY21FY22FY23FY24FY25
NIVF 41.7%VMD 5.5%
Revenue growth
NIVF FY2023: +44.3%NIVF FY2023: -13.6%NIVF FY2024: +5.8%NIVF FY2025: +336.3%VMD FY2019: +24.5%VMD FY2020: +63.6%VMD FY2021: -10.8%VMD FY2022: +18.6%VMD FY2023: +31.8%VMD FY2024: +22.5%VMD FY2025: +20.5%FY19FY20FY21FY22FY23FY24FY25
NIVF +336.3%VMD +20.5%
Free cash flow
NIVF FY2021: $1.4MNIVF FY2023: $1.6MNIVF FY2023: -$1.8MNIVF FY2024: -$8.3MNIVF FY2025: -$11.1MVMD FY2019: $16.3MVMD FY2019: $5.7MVMD FY2020: $22.1MVMD FY2021: $2.8MVMD FY2022: $4.9MVMD FY2023: $19.1MVMD FY2024: $1.3MVMD FY2025: $11.9MFY19FY20FY21FY22FY23FY24FY25
NIVF -$11.1MVMD $11.9M

Fiscal years as each company reports them; the two may end in different months.

Questions about NewGenIvf and Viemed Healthcare

Which is bigger by revenue, NewGenIvf or Viemed Healthcare?

Viemed Healthcare is bigger by revenue: $270.3M in fiscal 2025, against $23.7M for NewGenIvf in fiscal 2025.

Which keeps more of its revenue as profit, NewGenIvf or Viemed Healthcare?

NewGenIvf had a net margin of 41.7% in fiscal 2025; Viemed Healthcare had 5.5% in fiscal 2025.

Which grew revenue faster, NewGenIvf or Viemed Healthcare?

In their latest fiscal years revenue changed by +336.3% at NewGenIvf and +20.5% at Viemed Healthcare.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies